Word

PIONEER

Status

Registered

Status Code

700

Status Date

Tuesday, April 11, 2023

Serial Number

79329052

Registration Number

7021191

Registration Date

Tuesday, April 11, 2023

Mark Type

4000

Filing Date

Wednesday, October 6, 2021

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

Bio-Rad Europe GmbH - Original Registrant
Bio-Rad Laboratories GmbH - Original Applicant

Classifications

40 Antibody production for others, and manufacture of antibodies for others; custom manufacture of antibodies, namely, antibody purification, antibody fragmentation; custom production of cell cultures and biological products in the nature of antibodies and proteins and related reagents; custom antibody production; custom manufacturing for others, namely, manufacturing of chemical and biotechnological materials for others, namely, manufacturing of organisms, compounds and materials for use in the pharmaceutical, agrochemical, chemical, biotechnology industries

5 Biological preparations for the treatment of infectious diseases, deficiency diseases, hereditary diseases, and physiological diseases; pharmaceutical, biopharmaceutical and medical preparations for the treatment of infectious diseases, deficiency diseases, hereditary diseases, and physiological diseases; diagnostic preparations for medical purposes; antibodies for medical purposes; biological preparations, namely, immunoglobulins, antibodies, or fragments thereof, for medical use; antibody libraries, for medical and veterinary use, namely, collections of antibodies for medical purposes; libraries of immunoglobulins, antibodies, or fragments thereof, for medical use, namely, collections of biological preparations in the nature of immunoglobulins, antibodies, or fragments thereof, for medical use, sold as a unit; biological preparations comprised of immunoglobulins, antibodies, or fragments thereof, for use in medicine; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical clinician or medical use

1 Chemicals for use in industry and science, namely, diagnostic kits consisting primarily of antibodies and reagents for use in disease testing; biological preparations in the nature of antibodies for research use, other than for medical or veterinary purposes; antibody libraries, for scientific, industrial or research use, namely, biological preparations in the nature of antibodies sold together; libraries of immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use, namely, biological preparations in the nature of immunoglobulins, antibodies, or fragments thereof sold together as a kit; biological preparations in the nature of immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use; assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; reagents and kits comprising chemical reagents, both for scientific or research use in the field of diagnosing diseases

42 Research and development in the field of antibody generation services; medical and scientific research for the identification, preparation, and development of antibody libraries; Chemical, biochemical, biological and bacteriological research and analysis services in the nature of preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins; design of antibody libraries for medical or veterinary use; scientific and technological services, namely, scientific and technological research, analysis, inspection, quality audit, consulting, design, engineering, development and laboratory testing services for others; research and development services in the field of developing new chemicals; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals for use in medicines, reagents for use in medicines, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific laboratory services being scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; scientific laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, protein chemist; chemical and biological analysis and research services; pharmaceutical, medical, scientific and biopharmaceutical research and development; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines

Trademark Events

Aug 14, 2023

Final Decision Transaction Processed By Ib

Jul 26, 2023

Final Disposition Notice Sent To Ib

Jul 26, 2023

Final Disposition Processed

Jul 11, 2023

Final Disposition Notice Created, To Be Sent To Ib

Apr 11, 2023

Notice Of Registration Confirmation Emailed

Apr 11, 2023

Registered-Principal Register

Jan 24, 2023

Notification Processed By Ib

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Possible Opposition Sent To Ib

Jan 4, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 20, 2022

Approved For Pub - Principal Register

Dec 20, 2022

Examiner's Amendment Entered

Dec 20, 2022

Notification Of Examiners Amendment E-Mailed

Dec 20, 2022

Examiners Amendment E-Mailed

Dec 20, 2022

Examiners Amendment -Written

Dec 14, 2022

Teas/Email Correspondence Entered

Dec 14, 2022

Correspondence Received In Law Office

Dec 14, 2022

Teas Response To Office Action Received

Jul 19, 2022

Refusal Processed By Ib

Jun 25, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Jun 25, 2022

Refusal Processed By Mpu

Jun 17, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Jun 16, 2022

Non-Final Action Written

Jun 15, 2022

Assigned To Examiner

Jun 3, 2022

Change Of Owner Received From Ib

Jan 4, 2022

Application Filing Receipt Mailed

Dec 29, 2021

New Application Office Supplied Data Entered

Dec 23, 2021

Sn Assigned For Sect 66a Appl From Ib